Dimensional Fund Advisors LP Incyte Corp Transaction History

Dimensional Fund Advisors LP

$449 Billion
Q3 2025

A detailed history of Dimensional Fund Advisors LP transactions in Incyte Corp stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 1,596,129 shares of INCY stock, worth $166 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,596,129

Previous 1,387,962 15.0%

Holding current value

$166 Million

Previous $94.5 Million 43.22%

% of portfolio

0.03%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$67.27 - $86.96 $14 Million - $18.1 Million	208,167 Added 15.0%	1,596,129 $135 Million
Q2 2025 Aug 12, 2025	BUY	$55.17 - $71.22 $3.02 Million - $3.9 Million	54,787 Added 4.11%	1,387,962 $94.5 Million
Q1 2025 May 13, 2025	BUY	$60.0 - $75.26 $460,200 - $577,244	7,670 Added 0.58%	1,333,175 $80.7 Million
Q4 2024 Feb 13, 2025	SELL	$65.08 - $83.38 $5.67 Million - $7.26 Million	-87,083 Reduced 6.16%	1,325,505 $91.6 Million
Q3 2024 Nov 07, 2024	BUY	$57.33 - $68.61 $13.3 Million - $15.9 Million	231,319 Added 19.58%	1,412,588 $93.4 Million

Q2 2024 Aug 09, 2024	BUY	$51.18 - $63.75 $11.8 Million - $14.7 Million	230,665 Added 24.27%	1,181,269 $71.6 Million
Q1 2024 May 10, 2024	SELL	$56.55 - $66.59 $1,244 - $1,464	-22 Reduced -0.0%	950,604 $54.2 Million
Q4 2023 Feb 07, 2024	BUY	$52.16 - $64.19 $3.25 Million - $4 Million	62,380 Added 7.02%	950,626 $59.7 Million
Q3 2023 Nov 09, 2023	BUY	$57.77 - $65.93 $2.47 Million - $2.82 Million	42,762 Added 5.06%	888,246 $51.3 Million
Q2 2023 Aug 09, 2023	BUY	$60.95 - $75.51 $5.66 Million - $7.01 Million	92,894 Added 12.34%	845,484 $52.6 Million
Q1 2023 May 12, 2023	BUY	$70.23 - $86.01 $3.15 Million - $3.85 Million	44,793 Added 6.33%	752,590 $54.4 Million
Q4 2022 Feb 09, 2023	BUY	$67.18 - $84.11 $1.32 Million - $1.65 Million	19,596 Added 2.85%	707,797 $56.9 Million
Q3 2022 Nov 10, 2022	BUY	$66.18 - $82.86 $5 Million - $6.26 Million	75,522 Added 12.33%	688,201 $45.9 Million
Q2 2022 Aug 12, 2022	BUY	$66.18 - $83.18 $1.1 Million - $1.39 Million	16,657 Added 2.79%	612,679 $46.5 Million
Q1 2022 May 13, 2022	BUY	$66.02 - $79.71 $2.85 Million - $3.44 Million	43,168 Added 7.81%	596,022 $47.3 Million
Q4 2021 Feb 09, 2022	BUY	$63.34 - $74.11 $1.53 Million - $1.79 Million	24,186 Added 4.57%	552,854 $40.6 Million
Q3 2021 Nov 12, 2021	BUY	$68.67 - $84.02 $5.04 Million - $6.17 Million	73,377 Added 16.12%	528,668 $36.4 Million
Q2 2021 Aug 12, 2021	BUY	$79.87 - $87.53 $3.89 Million - $4.27 Million	48,741 Added 11.99%	455,291 $38.3 Million
Q1 2021 May 14, 2021	SELL	$76.02 - $100.5 $346,347 - $457,878	-4,556 Reduced 1.11%	406,550 $33 Million
Q4 2020 Feb 25, 2021	BUY	$80.74 - $97.7 $33.2 Million - $40.2 Million	411,106 New	411,106 $35.8 Million

Others Institutions Holding INCY

# of Institutions

797

Shares Held

205M

Call Options Held

638K

Put Options Held

635K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $23.2B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Incyte Corp Transaction History